Beijing Wehand-bio Pharmaceutical Co., Ltd

This early-stage study tested a new chemotherapy drug called WH002 against a standard drug (paclitaxel) for women with HER2-negative breast cancer. The goal was to see if WH002, given before surgery along with other drugs, was safer or worked better at shrinking tumors. The trial…

This early-stage study tested the safety and how the body processes a new tablet made from mulberry twig alkaloids. It involved 62 healthy and overweight volunteers in China. The main goal was to see if the tablets were safe and to measure how much of the drug gets into the blood…